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INTRODUCTION 
This study aimed to a comprehensive evaluation of Praziquantel 
(PZQ, a BCS II class drug) behavior upon the milling process in 
vibrational mill considering the influence of milling temperature 
(cryogenic vs room temperature), frequency, time and presence of 
different polymers (milled raw PZQ vs comilled PZQ-
crospovidone and PZQ-povidone at 1:1 wt ratio) on two 
experimental responses (residual crystallinity and PZQ recovery), 
as depicted in Fig. 1.  
 
 
Figure 1:  Graphical abstract 
MATERIALS AND METHODS 
Materials 
Praziquantel (Ph. Eur. grade donated by Fatro S.p.A.); PZQ 
impurity A and impurity B Ph. Eur. grade from Endotherm Gmbh; 
Povidone (Fluka Chemie-PVP) and micronized crospovidone 
(BASF-CROS). Methanol (Ph. Eur. for HPLC Gradient Grade-
VWR Chemicals BHD PROLABO®). 
Milling experiments 
Before grinding, PZQ and each polymer (PVP, CROS) were 
manually mixed in an agate mortar in a 1:1 wt ratio for 3 min. The 
grinding process was performed in a vibrational mill-Retsch 
MM400 (Retsch GmbH, Haan, Germany) 35 ml zirconium oxide 
jars, using 1.072 g of powder per jar and three 15 mm spheres, as 
previously [1]. PZQ was ground by itself and in combination with 
the polymers (PVP or CROS) one by one. No cooling was 
provided to the grinding jar during room temperature (RT) 
milling. For cryogrinding (CC) experiments, prior to milling, the 
jars containing the samples were immersed in liquid nitrogen for 1 
minute every 15 minutes of milling. Vibrational frequency and  
milling duration were varied according to the experimental plan 
below reported (Table 1).  
Sample temperature measurement  
Temperatures of the samples were recorded using a 35XP-A 
Amprobe K-type thermocouple (Amprobe, Test Tools Europe). 
Averaged measurements were from three replicates.  
Experimental Design 
For planning the milling trials, a factorial design was employed by 
means of JMP software (SAS Institute Inc). The variables were 
considered at different levels as reported in table 1. A number of 
23 x 3 duplicated trials (total trial number=48) were conducted in 
random order to reduce systematic error. 
 
Experimental 
Variables 
 
Levels 
Time (min) 30 90 
Frequency (Hz) 15 25 
Temperature room (RT) cryogenic (CC) 
Product 
Formulation 
PZQ PZQ: 
PVP (1:1) 
PZQ: 
CROS (1:1) 
Experimental 
Responses  
Y1 Drug 
Recovery % 
Y2 Residual 
Crystallinity % 
Table 1: The process (milling) and formulation factors, test 
levels, and experimental responses 
Determination of Experimental responses 
The quantification of PZQ was assessed using a HPLC method 
adapted from literature [2] and suitably modified according to our 
analytical system [1]. 
Drug residual crystallinity was calculated by the measurements 
(by Differential Scanning Calorimetry) of the enthalpy of fusion 
(∆H) of the PZQ using the equation: residual cristallinity (%) = 
(∆Hsample x 100) / ∆HPZQ.  
Statistical analysis  
Statistical analysis was performed by using JMP software, 
considering the physical variables (time and frequency) as 
continuous-numerical variables.  The screening of the effects was 
performed by a multiple comparison of each level against a 
control level (Dunnett's test).  
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RESULTS AND DISCUSSION 
Powder temperature was found to increase with increased milling 
frequency and time, up to maximum recorded value of 46.9°C, 
when milling at 25 Hz (for 90 min in the ambient conditions). 
Interestingly, by comparing the temperatures detected in identical 
operating conditions, the values are almost superimposable in the 
three powder systems (PZQ, PZQ:PVP, PZQ:CROS, Figure 2). 
 
 
Figure 2. Average powder temperature vs milling time at 
different frequencies at RT (solid lines) and in CC (dashed 
lines). 
 
The effects of the variation of factor levels on both experimental 
responses are reported in following Tables 2 and 3. 
 Y1 Drug recovery 
 PZQ PZQ-PVP (1:1) 
PZQ-CROS 
(1:1) 
Milling parameters p-value p-value p-value 
 
Time (30) 
 
n.s. 
*** 
p<.001 
***  
p<.001 
 
Frequency (15) 
 
n.s. 
*** 
p<.001 
***  
p<.001 
 
Temp. cond (RT) 
 
n.s. 
 
n.s. 
 
n.s. 
 Y2 Drug residual crystallinity 
 PZQ PZQ-PVP PZQ-CROS 
Milling parameters p-value p-value p-value 
 
Time (30) 
 
n.s. 
 
n.s. 
* 
p=.015 
 
Frequency (15) 
*** 
p=.006 
 
n.s. 
** 
p=.007 
 
Temp.cond. (RT) 
*** 
p<.001 
 
n.s. 
 
n.s. 
 
Table 2. Effect of variations of parameters on experimental 
responses. Comparison of each level against a control level                
(in brackets). 
 
Praziquantel recovery after neat grinding by itself remained 
unchanged, highlighting its resistance and optimal propensity to 
mechanochemical activation, since even increasing frequency or 
time of grinding no tendency to drug degradation was noticed. On 
the contrary the presence of the polymers in the systems favored a 
certain drug degradation at ambient temperature, that could be 
minimized using cryogenic conditions.  
When considering drug crystallinity degree upon grinding at RT 
conditions, the presence of the polymers promoted a high de-
structuration of the drug, while in the system only based on PZQ a 
similar amorphisation could be achieved exclusively using 
cryogenic conditions.  
CONCLUSION 
The results reported in this work highlight the role of both 
polymers as catalyst toward physical de-structuration and 
chemical degradation of the drug upon milling. The use of a 
cryogenic environment appeared as a necessity for a pronounced 
physical de-structuration, also preserving the chemical integrity of 
the drug. 
 
 Y1 Drug recovery Y2 Drug residual 
Crystallinity 
 RT  CC RT  CC 
Parameters p-value p-value p-value p-value 
Time  
(30) 
 
n.s. 
 
n.s. 
 
n.s. 
*** 
p<.001 
Frequency 
(15) 
* 
p=.027 
 
n.s. 
 
n.s. 
*** 
p<.001 
Presence of 
PVP 
(PZQ) 
*** 
p<.001 
*** 
p<.001 
*** 
p<.001 
*** 
p<.001 
Time  
(30) 
 
n.s. 
 
n.s. 
 
n.s. 
** 
p=.003 
Frequency 
(15) 
* 
p=.038 
 
n.s. 
 
n.s. 
*** 
p<.001 
Presence of 
CROS (PZQ) 
*** 
p<.001 
*** 
p<.001 
*** 
p<.001 
** 
p=.007 
Time  
(30) 
***  
p<.001 
 
n.s. 
 
n.s. 
** 
p=.006 
Frequency 
(15) 
*** 
p<.001 
 
n.s. 
 
n.s. 
*** 
p<.001 
Polymer 
choice 
(PVP) 
 
n.s. 
 
n.s. 
 
n.s. 
 
n.s. 
Table 3. Effect of variations of parameters on experimental 
responses. Comparison of each level against a control level          
(in brackets). 
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